Imbio PHA (4.0.0) vs HealthCCSng
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if you require rapid, automated analysis of cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation. This tool is specifically designed to aid in the diagnosis and risk stratification of acute conditions such as pulmonary embolism and hypertension, providing critical measurements and ratios quickly.
View Imbio PHA (4.0.0) →Choose HealthCCSng if…
Choose HealthCCSng if your objective is to opportunistically screen for coronary artery disease risk by automatically detecting and quantifying coronary artery calcification (CAC) from routine, non-contrast chest CT scans. This solution is ideal for identifying patients at risk of CAD and integrating seamlessly into existing PACS/EMR workflows for population health initiatives, without requiring dedicated cardiac CT protocols.
View HealthCCSng →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | HealthCCSng |
|---|---|---|
| Pricing | Unknown | Not publicly available |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud-based, integrates with PACS and EMR systems |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HealthCCSngBoth tools offer automated workflows and integrate with existing PACS/EMR systems for seamless clinical integration. However, HealthCCSng V2.0 provides enhanced usability with numerical CAC scoring, a new zero CAC category, and customizable category configurations, offering more granular and flexible information for clinicians in their standard workflow. Imbio PHA provides annotated DICOMs and PDF reports, which are standard, but HealthCCSng's recent updates suggest a slightly more refined and actionable output for clinical interpretation.
Clinical Value
HealthCCSngBoth tools offer significant clinical value in cardiovascular assessment. Imbio PHA aids in the diagnosis and risk stratification of pulmonary embolism and hypertension from CTPA scans. HealthCCSng, however, demonstrates a broader population health impact by opportunistically detecting and quantifying coronary artery calcification (CAC) from routine, non-cardiac-gated, non-contrast CT scans, identifying previously undetected patients at risk of coronary artery disease and enabling earlier intervention.
Pricing & Value
HealthCCSngNeither tool provides publicly available pricing information, making a direct cost comparison impossible. However, HealthCCSng explicitly mentions having CPT Code III (0721T & 0722T) for service reimbursement, which provides a clear pathway for healthcare providers to recover costs and potentially generate revenue. This offers a more tangible and transparent value proposition for a healthcare system compared to Imbio PHA, which does not detail reimbursement pathways.
Enterprise Readiness
Imbio PHA (4.0.0)Both tools are FDA-cleared and HIPAA compliant, which are fundamental for enterprise deployment. Imbio PHA offers flexible deployment options including cloud, enterprise (on-premise), or via partners, catering to a wider range of IT infrastructures. Additionally, Imbio PHA specifies third-party certification for HIPAA compliance, indicating a robust commitment to data security and regulatory adherence.
Innovation
HealthCCSngWhile both tools utilize AI for advanced medical image analysis, HealthCCSng demonstrates a higher degree of innovation by leveraging AI to opportunistically detect and quantify coronary artery calcification from *routine, non-contrast, non-ECG gated chest CT scans*. This approach transforms incidental findings into actionable insights for population health, offering a novel pathway for early disease detection and prevention without requiring dedicated cardiac imaging.
Support & Docs
Imbio PHA (4.0.0)Imbio PHA provides clear indications of support resources, including a dedicated 'support-documentation' section on its website for user manuals and an email address for technical support inquiries. In contrast, specific details regarding HealthCCSng's dedicated support channels or comprehensive documentation are less prominently featured in the available information, making Imbio PHA appear more transparent and accessible in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | HealthCCSng |
|---|---|---|
| Name | Imbio PHA (4.0.0) | HealthCCSng |
| Primary Analysis/Use Case | Measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. |
| Key Measurements/Output | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Generates annotated DICOM images; Provides summary reports in PDF format. | Automatically detects and quantifies coronary artery calcification (CAC); Categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories; Generates a numerical calcium score; Provides visualization of calcified plaques within coronary arteries. |
| Integration | Integrates with native DICOM tools and workflows | Seamless integration with PACS and EMR systems |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Radiology |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and HealthCCSng.